Business context and reporting period
This filing is by LRAD Corporation, which designs and sells directed-acoustic products. The request identifies Genasys Inc.; the filing itself does not identify Genasys, so verify the issuer and filing match. The report covers the quarter and six months ended March 31, 2013, in the company’s fiscal year.
Financial results and liquidity
| Metric | Three months ended March 31, 2013 | Six months ended March 31, 2013 |
|---|---|---|
| Revenue | $3.19 million | $6.17 million |
| Gross profit / margin | $1.36 million / 42.7% | $2.85 million / 46.2% |
| Operating income (loss) | ($465,000) | ($574,000) |
| Net income (loss) | ($459,000) | ($560,000) |
| Net loss per share, basic and diluted | ($0.01) | ($0.02) |
- For the six months, operating cash flow was $1.99 million, investing cash outflow was $86,000, and financing cash inflow was $19,000. Cash increased $1.92 million.
- At March 31, cash was $15.78 million; working capital was $21.28 million. Current assets were $23.40 million and current liabilities $2.12 million.
- Accounts receivable was $2.35 million, down from $5.52 million at September 30, 2012; inventory was $4.87 million, up from $3.11 million.
- The company reported no debt. It said available cash and expected operating cash flows were sufficient for the next 12 months under planned spending and operating assumptions, while noting additional financing might be needed if conditions change.
Changes versus prior comparable periods
- Quarterly revenue rose 32.9% year over year, largely from timing of order receipts and deliveries; product sales increased 23.4% and contract and other revenue increased to $302,000, including $197,000 from a foreign-military annual maintenance agreement.
- Quarterly gross margin fell to 42.7% from 54.9%. Management cited product mix, higher maintenance costs versus first-year warranty costs on a prior large sale, and the absence of a prior-year warranty-reserve reduction.
- Quarterly net loss widened to $459,000 from $292,000, as higher operating expenses more than offset increased revenue and gross profit. SG&A included higher legal and professional fees tied to litigation and a threatened proxy contest.
- Six-month revenue increased 2.6%, but product sales declined 4.0%; contract and other revenue rose, including $394,000 from the maintenance agreement. Gross margin fell to 46.2% from 51.0%, and the company shifted from $22,000 net income to a $560,000 net loss.
- Six-month operating cash flow improved from $37,000 to $1.99 million, primarily reflecting lower receivables; inventory growth partly offset the cash benefit.
Outlook, risks and unusual items
- Management expected uneven quarterly revenue and said U.S. defense spending delays from sequestration and the delayed FY2013 continuing resolution continued to affect the business. It expected some domestic government and military funding to begin in the quarter ending June 30, 2013; no quantified revenue or earnings guidance was provided.
- The company cited uncertainty around the FY2014 federal budget and Overseas Contingency Operations funding, international economic and geopolitical conditions, uncertain timing or completion of large opportunities, product acceptance, competition, product mix, and inventory levels.
- Management expected R&D spending to remain broadly comparable to the prior year and anticipated additional legal expense in the third fiscal quarter. Historical gross margins were not considered a reliable indicator of future margins.
- A shareholder derivative suit alleges that director and executive stock options violated the 2005 equity plan. A motion to dismiss was pending after a March 4, 2013 hearing. Management considered a loss not probable and recorded no accrual, but estimated a reasonably possible loss of $0 to $600,000 after expected insurance recoveries and potential claim adjustments. The shareholder also announced an intention to nominate five directors.
- Approximately $15.6 million of cash deposits exceeded FDIC insurance limits. The company reported no losses on such deposits. Customer concentration was notable: three customers represented 20%, 15%, and 14% of quarterly revenue; four customers represented 34%, 14%, 12%, and 10% of receivables.
- Federal and state net operating losses were subject to a full valuation allowance. The company said its expected annual effective tax rate was zero, although it recorded $1,600 of tax expense for the six-month period.
Important facts for investors to verify
- Confirm the filing’s issuer: it is LRAD Corporation, not Genasys Inc., despite the request metadata.
- Assess whether revenue timing, defense-budget delays, customer concentration, and maintenance-contract revenue make reported sales repeatable.
- Track gross margins, inventory growth, receivable collections, and whether operating cash generation continues beyond this period’s working-capital benefits.
- Monitor the derivative litigation, potential loss range, proxy contest, and related legal costs.
- Review the latest liquidity outlook, funding conditions, and any subsequent changes to the company’s stated 12-month cash sufficiency assessment.